Get the Stockscreener App
0.3686
3.83%
0.0136
Biomerica Inc stock is traded at $0.3686, with a volume of 48,398.
It is up +3.83% in the last 24 hours and up +13.42% over the past month.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
See More
Previous Close:
$0.355
Open:
$0.362
24h Volume:
48,398
Relative Volume:
0.11
Market Cap:
$5.94M
Revenue:
$5.41M
Net Income/Loss:
$-6.35M
P/E Ratio:
-0.7372
EPS:
-0.5
Net Cash Flow:
$-5.39M
1W Performance:
+18.52%
1M Performance:
+13.42%
6M Performance:
-34.18%
1Y Performance:
-57.14%
1-Day Range:
$0.35
$0.372
1-Week Range:
$0.311
$0.4354
52-Week Range:
$0.2415
$2.13
Biomerica Inc Stock (BMRA) Company Profile
Name
Biomerica Inc
Sector
Industry
Phone
(949) 379-2875
Address
17571 VON KARMAN AVENUE, IRVINE, CA
Biomerica Inc Stock (BMRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-10-20 | Initiated | Colliers Securities | Buy |
| Jan-04-18 | Initiated | B. Riley FBR, Inc. | Buy |
Biomerica Inc Stock (BMRA) Latest News
Biomerica Gains on IBS Announcement - Baystreet.ca
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain - The Manila Times
Biomerica Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Japan Point of Care Test Market By Application - Third Eye News
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Quantisnow
Blood Testing Market Size, Growth, Opportunities 2024-2032 | - openPR
Blood Testing Instrument Market 2031 Research Report, Growth Trends And Competition | Genteel, Baxter, Danaher, Hologic, Biomerica, Meridian Bioscience, Abbott – Times-BD24 - Times-BD24
Blood Testing Market Reaches USD 169.15 Billion by 2032 Due - GlobeNewswire
Artificial intelligence: who are the leaders in personalized food recommendation for the consumer industry? - just-food.com
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Increases By 582.1% - Defense World
Industrial Microbiology Market Share and Size 2024 In The Latest Report - WhaTech
Short Interest in Biomea Fusion, Inc. (NASDAQ:BMEA) Expands By 7.8% - Defense World
Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India
Bokf Na Acquires Shares of 375 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Cut to $115.00 by Analysts at Bank of America - Defense World
BioMarin price target lowered to $115 from $130 at BofA - TipRanks
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Acadian Asset Management LLC - Defense World
BioE3 Policy implementation and potential in Futuristic growth of J&K - Daily Excelsior
Nasdaq Gains 100 Points; Biomerica Shares Spike Higher - MSN
The United States Blood Testing Market Size & Outlook, 2030 - Grand View Research
Views of Wall Street’s Leading Experts on Biomerica Inc. - SETE News
Biomerica Inc. [BMRA] Stock trading around $0.38 per share: What’s Next? - The DBT News
BMRA’s 2023 Market Dance: Down -70.48% – Time to Invest? - The InvestChronicle
Saudi Arabia approves Biomerica's prostate cancer test - Investing.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica’s At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - ForexTV.com
The Saudi Food and Drug Authority (SFDA) Approves Biomerica's At Home PSA Screening Test to Detect Early Signs of Prostate Cancer - StockTitan
Financial Metrics Exploration: Understanding Biomerica Inc. (BMRA) Through Ratios - The Dwinnex
Biomerica Full Year 2024 Earnings: US$0.35 loss per share (vs US$0.50 loss in FY 2023) - Yahoo Finance
Biomerica Reports Fiscal 2024 Year End Results - ForexTV.com
Biomerica (NASDAQ:BMRA) Stock Crosses Below 200-Day Moving Average of $0.66 - Defense World
Biomerica stock plunges to 52-week low of $0.28 - Investing.com India
Biomerica (NASDAQ:BMRA) Share Price Crosses Below 200 Day Moving Average of $0.76 - Defense World
Salmonella Testing Market Anticipated To Reach A CAGR Of 7.8% By 2031, Share, Size, Growth, Demand, And Seg... - WhaTech
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 54.4% in June - Defense World
BMRABiomerica, Inc. Latest Stock News & Market Updates - StockTitan
Biomerica (NASDAQ:BMRA) Stock Passes Below 200-Day Moving Average of $0.83 - Defense World
Is Biomerica Inc. (BMRA) a good investment opportunity? – US Post News - US Post News
Financial Analysis: Biomerica Inc. (BMRA)'s Ratios Unveil Key Insights – DWinneX - The Dwinnex
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - StockTitan
Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS ... - Afternoon Headlines
Biomerica (NASDAQ:BMRA) Stock Crosses Below Two Hundred Day Moving Average of $0.86 - Defense World
Biomerica Chairman Jack Kenny steps down By Investing.com - Investing.com Australia
Biomerica Chairman Jack Kenny Resigns Suddenly - TipRanks
Biomerica Chairman Jack Kenny steps down - Investing.com
Helicobacter Pylori Diagnostics Market Gaining Momentum with Positive External Factors - Taiwan News
Biomerica, Inc.'s (NASDAQ:BMRA) Path To Profitability - Yahoo New Zealand News
Biomerica Inc. (BMRA)’s financial ratios: A comprehensive overview - The Dwinnex
All Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market - Yahoo Movies UK
Russell Investments Group Ltd. Purchases 26288 Shares of Biomerica, Inc. (NASDAQ:BMRA) - Defense World
Macy's, Inc. (NYSE:M) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
What Did Biomerica's (NASDAQ:BMRA) CEO Take Home Last Year? - Yahoo Canada Shine On
Biomerica Inc Stock (BMRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):